Teva Pharmaceutical Industries ADR (TEVA)

$18.05 -0.10 (-0.55%)
Market Cap 20.78B
Revenue (ttm) 16.54B
Net Income (ttm) -1.64B
EPS (ttm) N/A
PE Ratio 7.38
Forward PE 7.64
Profit Margin -9.91%
Debt to Equity Ratio 2.52
Volume 8,017,291
Avg Vol 11,474,146
Day's Range N/A - N/A
Shares Out 1.15B
Stochastic %K 46%
Beta 0.62
Analysts Strong Sell
Price Target $23.75

Company Profile

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 972 3 914 8213
Address:
124 Dvora HaNevi’a St., Tel Aviv, Israel
LakersandVRX
LakersandVRX Aug. 27 at 6:45 PM
$TEVA truth is I think there are a lot of smart ppl on this board. That’s probably why no one ever overpays for this stock. Stock price goes no where often and nvr gains traction. Stock never overvalues. A good poker player knows you win a lot of $ by playing fools.
0 · Reply
scientificway
scientificway Aug. 27 at 5:40 PM
$TEVA strong buy, XTNT revenue up year over year. growth for sure, how much after a year
0 · Reply
topshelf95
topshelf95 Aug. 27 at 5:38 PM
$TEVA consolidating before the next run up.
0 · Reply
Terrordomo80
Terrordomo80 Aug. 27 at 2:37 PM
$TEVA even when it looks like its gonna break out it still always falls flat on its face... youll never make an easy buck here unless its tonl the downside after a double digit percentage move up... same ol pos...
0 · Reply
NNJAWINLIVE
NNJAWINLIVE Aug. 27 at 11:15 AM
$TEVA 30 plus
1 · Reply
LakersandVRX
LakersandVRX Aug. 27 at 2:07 AM
$TEVA ppl need to stop whining. If someone says the stock will go up to 30…it’s ok. If some say it will go to 10…it’s ok too. Yes, the Econ dept at UCLA does teach stock charts bc it’s not a science.
0 · Reply
Hopewisper
Hopewisper Aug. 26 at 10:09 PM
$TEVA 25$...
2 · Reply
InItToLoseItAll
InItToLoseItAll Aug. 26 at 9:27 PM
$TEVA Congrats bulls $20 tm
0 · Reply
LakersandVRX
LakersandVRX Aug. 26 at 7:14 PM
$TEVA wow, can this climb have been any slower. I’ll take it still.
0 · Reply
NNJAWINLIVE
NNJAWINLIVE Aug. 26 at 2:49 PM
$TEVA 30
0 · Reply
Latest News on TEVA
Teva Debuts Autumn Winter 2025 Collection Inspired By “For Playground Earth”

Aug 19, 2025, 9:00 AM EDT - 8 days ago

Teva Debuts Autumn Winter 2025 Collection Inspired By “For Playground Earth”

US FDA approves Teva's Ajovy for migraine prevention in children

Aug 5, 2025, 6:16 PM EDT - 21 days ago

US FDA approves Teva's Ajovy for migraine prevention in children

Teva's Big Pharma Comeback: Why I Think The Market Is Still Missing The Upside

Jul 31, 2025, 3:27 PM EDT - 27 days ago

Teva's Big Pharma Comeback: Why I Think The Market Is Still Missing The Upside

Teva CEO: Our supply chain puts us in a strong position

Jul 30, 2025, 12:40 PM EDT - 4 weeks ago

Teva CEO: Our supply chain puts us in a strong position

Teva Pharmaceutical Industries Limited (TEVA) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 11:50 AM EDT - 4 weeks ago

Teva Pharmaceutical Industries Limited (TEVA) Q2 2025 Earnings Call Transcript

Teva Pharm Q2 profit beats estimates as branded drugs gain

Jul 30, 2025, 7:21 AM EDT - 4 weeks ago

Teva Pharm Q2 profit beats estimates as branded drugs gain

Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong

Jul 29, 2025, 2:44 PM EDT - 4 weeks ago

Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong

Teva Releases Q2 2025 Aide Memoire

Jun 26, 2025, 4:30 PM EDT - 2 months ago

Teva Releases Q2 2025 Aide Memoire

Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025

Jun 25, 2025, 4:30 PM EDT - 2 months ago

Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025

Final Data from Teva's PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine

Jun 23, 2025, 3:00 AM EDT - 2 months ago

Final Data from Teva's PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

Jun 16, 2025, 9:03 AM EDT - 2 months ago

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

Teva Pharmaceutical Industries Limited (TEVA) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Jun 10, 2025, 11:46 AM EDT - 2 months ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Teva Pharmaceutical Industries Limited (TEVA) Presents at Jefferies Global Healthcare Conference Transcript

Jun 5, 2025, 7:09 AM EDT - 2 months ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Jefferies Global Healthcare Conference Transcript

Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer

Jun 3, 2025, 5:30 PM EDT - 3 months ago

Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer

Teva Announces Early Tender Results of its Debt Tender Offer, Increase to Tender Pool Caps and Total Maximum Amount and Election of Early Settlement

Jun 3, 2025, 7:16 AM EDT - 3 months ago

Teva Announces Early Tender Results of its Debt Tender Offer, Increase to Tender Pool Caps and Total Maximum Amount and Election of Early Settlement

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

May 30, 2025, 9:05 PM EDT - 3 months ago

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-'749 (olanzapine) to Date

May 30, 2025, 9:00 PM EDT - 3 months ago

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-'749 (olanzapine) to Date

Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day

May 29, 2025, 8:00 AM EDT - 3 months ago

Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA

May 27, 2025, 5:30 PM EDT - 3 months ago

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June

May 27, 2025, 4:30 PM EDT - 3 months ago

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June

Why Is Teva Stock Trading Higher On Tuesday?

May 27, 2025, 3:44 PM EDT - 3 months ago

Why Is Teva Stock Trading Higher On Tuesday?

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma

May 27, 2025, 8:30 AM EDT - 3 months ago

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma

Why Investors Should Watch Teva Despite Regional Risks

May 23, 2025, 12:52 PM EDT - 3 months ago

Why Investors Should Watch Teva Despite Regional Risks

Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes

May 22, 2025, 1:56 PM EDT - 3 months ago

Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes

Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt

May 20, 2025, 5:22 PM EDT - 3 months ago

Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt

Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy

May 20, 2025, 4:30 PM EDT - 3 months ago

Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031

May 19, 2025, 4:52 AM EDT - 3 months ago

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031

Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes

May 19, 2025, 4:52 AM EDT - 3 months ago

Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

May 15, 2025, 6:12 PM EDT - 3 months ago

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

Teva's Transformation: Why This 'Forgotten Pharma' Could Deliver 30% Upside

May 8, 2025, 11:33 AM EDT - 3 months ago

Teva's Transformation: Why This 'Forgotten Pharma' Could Deliver 30% Upside

Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says

May 7, 2025, 1:01 PM EDT - 4 months ago

Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says

Teva Shares Climb On Profit Beat, $700 Million Cost Plan, Biopharma Pivot Momentum

May 7, 2025, 12:13 PM EDT - 4 months ago

Teva Shares Climb On Profit Beat, $700 Million Cost Plan, Biopharma Pivot Momentum

Teva CEO Richard Francis on tariffs: Well positioned to maintain guidance despite duties

May 7, 2025, 11:51 AM EDT - 4 months ago

Teva CEO Richard Francis on tariffs: Well positioned to maintain guidance despite duties

Teva Pharmaceutical Industries Limited (TEVA) Q1 2025 Earnings Call Transcript

May 7, 2025, 10:47 AM EDT - 4 months ago

Teva Pharmaceutical Industries Limited (TEVA) Q1 2025 Earnings Call Transcript

Teva Pharm first-quarter profit rise tops estimates

May 7, 2025, 7:30 AM EDT - 4 months ago

Teva Pharm first-quarter profit rise tops estimates

Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City

May 7, 2025, 7:00 AM EDT - 4 months ago

Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved

May 7, 2025, 7:00 AM EDT - 4 months ago

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved

Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?

May 5, 2025, 11:43 AM EDT - 4 months ago

Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

May 5, 2025, 7:49 AM EDT - 4 months ago

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

Apr 9, 2025, 6:32 PM EDT - 4 months ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK JNJ LLY

Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out

Apr 9, 2025, 3:59 PM EDT - 5 months ago

Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out

ABBV AMGN AZN BMY GSK JNJ LLY

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

Apr 7, 2025, 7:30 AM EDT - 5 months ago

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

New Data Strengthens Teva's Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

Mar 31, 2025, 1:00 PM EDT - 5 months ago

New Data Strengthens Teva's Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

Teva Releases Q1 2025 Aide Memoire

Mar 27, 2025, 4:30 PM EDT - 5 months ago

Teva Releases Q1 2025 Aide Memoire

Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025

Mar 27, 2025, 4:30 PM EDT - 5 months ago

Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025

Drugmakers agree to participate in second round of price negotiations

Mar 14, 2025, 6:08 PM EDT - 5 months ago

Drugmakers agree to participate in second round of price negotiations

ABBV AZN GSK MRK NVO

Teva Pharmaceutical Industries Limited (TEVA) Leerink's 2025 Global Healthcare Conference (Transcript)

Mar 12, 2025, 12:15 PM EDT - 6 months ago

Teva Pharmaceutical Industries Limited (TEVA) Leerink's 2025 Global Healthcare Conference (Transcript)

Teva Pharmaceutical Industries Limited (TEVA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)

Mar 11, 2025, 1:07 PM EDT - 6 months ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)

Teva: Branded Momentum Clashes With Generic Declines And IRA Headwinds

Mar 6, 2025, 12:27 PM EST - 6 months ago

Teva: Branded Momentum Clashes With Generic Declines And IRA Headwinds

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

Mar 3, 2025, 4:30 PM EST - 6 months ago

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

LakersandVRX
LakersandVRX Aug. 27 at 6:45 PM
$TEVA truth is I think there are a lot of smart ppl on this board. That’s probably why no one ever overpays for this stock. Stock price goes no where often and nvr gains traction. Stock never overvalues. A good poker player knows you win a lot of $ by playing fools.
0 · Reply
scientificway
scientificway Aug. 27 at 5:40 PM
$TEVA strong buy, XTNT revenue up year over year. growth for sure, how much after a year
0 · Reply
topshelf95
topshelf95 Aug. 27 at 5:38 PM
$TEVA consolidating before the next run up.
0 · Reply
Terrordomo80
Terrordomo80 Aug. 27 at 2:37 PM
$TEVA even when it looks like its gonna break out it still always falls flat on its face... youll never make an easy buck here unless its tonl the downside after a double digit percentage move up... same ol pos...
0 · Reply
NNJAWINLIVE
NNJAWINLIVE Aug. 27 at 11:15 AM
$TEVA 30 plus
1 · Reply
LakersandVRX
LakersandVRX Aug. 27 at 2:07 AM
$TEVA ppl need to stop whining. If someone says the stock will go up to 30…it’s ok. If some say it will go to 10…it’s ok too. Yes, the Econ dept at UCLA does teach stock charts bc it’s not a science.
0 · Reply
Hopewisper
Hopewisper Aug. 26 at 10:09 PM
$TEVA 25$...
2 · Reply
InItToLoseItAll
InItToLoseItAll Aug. 26 at 9:27 PM
$TEVA Congrats bulls $20 tm
0 · Reply
LakersandVRX
LakersandVRX Aug. 26 at 7:14 PM
$TEVA wow, can this climb have been any slower. I’ll take it still.
0 · Reply
NNJAWINLIVE
NNJAWINLIVE Aug. 26 at 2:49 PM
$TEVA 30
0 · Reply
Terrordomo80
Terrordomo80 Aug. 26 at 1:41 PM
$TEVA
0 · Reply
Quantumup
Quantumup Aug. 26 at 12:24 PM
Piper Sandler reiterated $AQST Overweight-$5 and said: Encouraging Feedback On Anaphylm From Allergist-Focused Survey $SPRY $UNH $TEVA $VTRS Piper Sandler added:
3 · Reply
NNJAWINLIVE
NNJAWINLIVE Aug. 25 at 10:52 PM
$TEVA
0 · Reply
RunnerSignals
RunnerSignals Aug. 25 at 8:39 PM
more upgrades in play 3/3 $CMCO $RIVN $SLB $SO $TEVA all got upgrades today https://stocksrunner.com/news/2025-08-25-stock-upgrades-today-driving-market-buzz-and-gains
0 · Reply
LakersandVRX
LakersandVRX Aug. 25 at 8:06 PM
$TEVA I need to remind TEVA shareholders that Pipper reiterated buy today. That doesn’t mean take profits.
0 · Reply
Terrordomo80
Terrordomo80 Aug. 25 at 7:59 PM
$TEVA fkn turd! No surprise!
1 · Reply
CandleCrushera
CandleCrushera Aug. 25 at 7:09 PM
$TEVA UTRX TradingView showing strong buy across MAs and oscillators, chart cleaned up, trend building, breakout watch above prior range, thin tape moves fast
0 · Reply
OX50
OX50 Aug. 25 at 6:50 PM
$TEVA Argus Reiterated since 08/04/2025 Buy Market Edge Reiterated since 08/19/2025 Long View Research
0 · Reply
OX50
OX50 Aug. 25 at 6:49 PM
$TEVA Latest Report 08/24/2025 LSEG maintains a current price target of $24.00 for TEVA
0 · Reply
OX50
OX50 Aug. 25 at 6:48 PM
$TEVA
0 · Reply
OX50
OX50 Aug. 25 at 6:48 PM
$TEVA
0 · Reply
chris_e
chris_e Aug. 25 at 5:47 PM
$TEVA lol
0 · Reply